- Home
- RDHL vs JTAI Comparison
RDHL vs JTAI Comparison
Compare RDHL & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- JTAI
- Stock Information
- Founded
- RDHL 2009
- JTAI 2018
- Country
- RDHL Israel
- JTAI United States
- Employees
- RDHL N/A
- JTAI N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- JTAI Blank Checks
- Sector
- RDHL Health Care
- JTAI Finance
- Exchange
- RDHL Nasdaq
- JTAI Nasdaq
- Market Cap
- RDHL 3.9M
- JTAI 9.8M
- IPO Year
- RDHL N/A
- JTAI N/A
- Fundamental
- Price
- RDHL $1.46
- JTAI $2.52
- Analyst Decision
- RDHL
- JTAI Strong Buy
- Analyst Count
- RDHL 0
- JTAI 1
- Target Price
- RDHL N/A
- JTAI $11.00
- AVG Volume (30 Days)
- RDHL 1.4M
- JTAI 217.2K
- Earning Date
- RDHL 09-05-2025
- JTAI 11-13-2025
- Dividend Yield
- RDHL N/A
- JTAI N/A
- EPS Growth
- RDHL N/A
- JTAI N/A
- EPS
- RDHL N/A
- JTAI N/A
- Revenue
- RDHL $9,550,000.00
- JTAI $12,790,684.00
- Revenue This Year
- RDHL $381.91
- JTAI N/A
- Revenue Next Year
- RDHL N/A
- JTAI N/A
- P/E Ratio
- RDHL N/A
- JTAI N/A
- Revenue Growth
- RDHL 157.62
- JTAI N/A
- 52 Week Low
- RDHL $1.06
- JTAI $2.30
- 52 Week High
- RDHL $8.75
- JTAI $16.56
- Technical
- Relative Strength Index (RSI)
- RDHL 39.97
- JTAI 36.07
- Support Level
- RDHL $1.64
- JTAI $2.80
- Resistance Level
- RDHL $1.90
- JTAI $2.94
- Average True Range (ATR)
- RDHL 0.16
- JTAI 0.23
- MACD
- RDHL -0.04
- JTAI -0.02
- Stochastic Oscillator
- RDHL 2.86
- JTAI 10.98
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.